Cargando…
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873181/ https://www.ncbi.nlm.nih.gov/pubmed/33563902 http://dx.doi.org/10.1038/s41408-021-00409-3 |
| _version_ | 1783649333084684288 |
|---|---|
| author | Boons, Eline Nogueira, Tatiane C. Dierckx, Tim Menezes, Soraya Maria Jacquemyn, Maarten Tamir, Sharon Landesman, Yosef Farré, Lourdes Bittencourt, Achiléa Kataoka, Keisuke Ogawa, Seishi Snoeck, Robert Andrei, Graciela Van Weyenbergh, Johan Daelemans, Dirk |
| author_facet | Boons, Eline Nogueira, Tatiane C. Dierckx, Tim Menezes, Soraya Maria Jacquemyn, Maarten Tamir, Sharon Landesman, Yosef Farré, Lourdes Bittencourt, Achiléa Kataoka, Keisuke Ogawa, Seishi Snoeck, Robert Andrei, Graciela Van Weyenbergh, Johan Daelemans, Dirk |
| author_sort | Boons, Eline |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7873181 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78731812021-02-16 XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis Boons, Eline Nogueira, Tatiane C. Dierckx, Tim Menezes, Soraya Maria Jacquemyn, Maarten Tamir, Sharon Landesman, Yosef Farré, Lourdes Bittencourt, Achiléa Kataoka, Keisuke Ogawa, Seishi Snoeck, Robert Andrei, Graciela Van Weyenbergh, Johan Daelemans, Dirk Blood Cancer J Correspondence Nature Publishing Group UK 2021-02-01 /pmc/articles/PMC7873181/ /pubmed/33563902 http://dx.doi.org/10.1038/s41408-021-00409-3 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Boons, Eline Nogueira, Tatiane C. Dierckx, Tim Menezes, Soraya Maria Jacquemyn, Maarten Tamir, Sharon Landesman, Yosef Farré, Lourdes Bittencourt, Achiléa Kataoka, Keisuke Ogawa, Seishi Snoeck, Robert Andrei, Graciela Van Weyenbergh, Johan Daelemans, Dirk XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis |
| title | XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis |
| title_full | XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis |
| title_fullStr | XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis |
| title_full_unstemmed | XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis |
| title_short | XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis |
| title_sort | xpo1 inhibitors represent a novel therapeutic option in adult t-cell leukemia, triggering p53-mediated caspase-dependent apoptosis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873181/ https://www.ncbi.nlm.nih.gov/pubmed/33563902 http://dx.doi.org/10.1038/s41408-021-00409-3 |
| work_keys_str_mv | AT boonseline xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT nogueiratatianec xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT dierckxtim xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT menezessorayamaria xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT jacquemynmaarten xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT tamirsharon xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT landesmanyosef xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT farrelourdes xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT bittencourtachilea xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT kataokakeisuke xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT ogawaseishi xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT snoeckrobert xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT andreigraciela xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT vanweyenberghjohan xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis AT daelemansdirk xpo1inhibitorsrepresentanoveltherapeuticoptioninadulttcellleukemiatriggeringp53mediatedcaspasedependentapoptosis |